Celebrating Azami Global’s Top 100 of 2021
We are honored to recognize the law firms and purpose-driven leaders who have not only navigated their firms through unprecedented change, but also modeled what
We are honored to recognize the law firms and purpose-driven leaders who have not only navigated their firms through unprecedented change, but also modeled what
Looking back at the past decade, in 2013, filings of patent lawsuits in the United States were at an unprecedented high, and remained that way
Choice IP and The PCT Network join forces to create a new IP service provider: Azami Global [New York, New York, January 2022] -Today we
Australia stands apart from many other key jurisdictions in allowing first and second medical use claims drafted as “method of medical treatment” or “Swiss-form” claims.
FibroGen Inc. v Akebia Therapeutics Inc. and another company; Astellas Pharma Inc. v Akebia Therapeutics Inc. and other companies [2021] EWCA Civ 1279 What are the
When evaluating the novelty of claims in life sciences and pharmaceutical, compared with EPO, the examination practice in China is more stringent when determining whether
United States
82 Nassau St #60492
New York, NY 10038
__
1 North State Street
15th floor
Chicago, IL 60602
Singapore
7 Temasek Boulevard, #12-07
Suntec Tower One
Israel
2 Yitzhak Rabin
Bet Shemesh
Hong Kong
Tung Wai Commercial Building,
Suite 1404
109-111 Gloucester Road, Wan Chai
Copyright © 2022. All Rights Reserved.